EXCITE Caregiver Motor Activity Log Dataset in Extremity Constraint Induced Therapy Evaluation Trial

Data related to how much and how well a caregiver believes a participant uses their more affected arm, with values (0-5) based on the amount of use (“Amount” Scale or AS) and the quality of movement during the functional activities indicated (“How Well” Scale or HW)
Study Description
The first national, randomized, single-blind study to systematically test a neurorehabilitation therapy - constraint induced movement therapy (CIMT) - among patients with the ability to initiate extension movements at the wrist and fingers and who had experienced a first stroke within 3 to 9 months prior to enrollment. Participants recruited from 247 clinics nationwide were randomized to receive CIMT to the more impaired upper extremity for two weeks upon enrollment or to receive the identical intervention 15-21 months post-stroke. Outcome measures were the Wolf Motor Function Test (WMFT) and Motor Activity Log (MAL) for functional improvements and the Stroke Impact Scale (SIS) for health-related quality of life.
Individuals with sub-acute (3-6 months post-insult) ischemic or hemorrhagic stroke

本数据集涵盖护理者对受试者使用其症状更严重侧肢体（患肢）的频率与效果的评估相关数据，评分范围为0至5分，评估维度包括使用频率量表（Amount Scale，AS）与指定功能活动中的运动质量量表（How Well Scale，HW）。
研究概述
本研究为首个全国性随机单盲试验，旨在系统性检验约束诱导运动疗法（constraint induced movement therapy，CIMT）的神经康复效果。受试对象需满足：能够完成腕部与手指的伸展动作，且在入组前3至9个月内首次发生脑卒中。研究从全国247家临床机构招募受试者，将其随机分为两组：一组在入组后即刻接受为期两周的症状更严重侧上肢约束诱导运动疗法；另一组则在脑卒中发病后15至21个月时接受相同干预。本研究的结局指标包括用于评估功能改善的沃尔夫运动功能测试（Wolf Motor Function Test，WMFT）、运动活动日志（Motor Activity Log，MAL），以及用于评估健康相关生活质量的脑卒中影响量表（Stroke Impact Scale，SIS）。
患有亚急性脑卒中（发病后3至6个月）的缺血性或出血性脑卒中患者